Cytel, Inc.

Cytel, Inc.

Cytel, Inc.

Overview
Date Founded

1987

Headquarters

675 Massachusetts Avenue,Cambridge, MA 02139-3309

Type of Company

Private

Industries

Medical Products & Equipment
Holding Companies
Computer Software

Company Description

Cytel, Inc. provides clinical trial design services. The firm offers statistical applications for the bio-pharmaceutical, medical device, academic and government research markets. Its products include StatXact, LogXact, Egret, ToxTools and StaTable. The company was founded by Cyrus Mehta and Nitin patel in 1987 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Cytel, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder

Founder

Chief Executive Officer

Chief Financial Officer

Chief Human Resources Officer

Chief Executive Officer-Indian Operations

Senior Vice President-Clinical Research Services

Senior Vice President-Sales & Business Development

Senior Vice President-Research & Development

Vice President-Consulting, Software Solutions & Marketing

Board of Directors

Founder at Cytel, Inc.

Founder at Cytel, Inc.

Co-Founder at Decision Resources, Inc.

Former President & Chief Executive Officer, Merck Capital Ventures at Merck & Co., Inc.

Executive Vice President at PAREXEL International Corp.

Managing Director at New Mountain Capital LLC

Paths to Cytel, Inc.
Potential Connections via
Relationship Science
You
Cytel, Inc.
Advisors & Consultants
Advisor

Consulting Chief Financial Officer at Rive Technology, Inc.

Investors
Details Hidden

New Mountain Capital seeks to generate exceptional returns through investor value-added and growth rather than debt. The firm's private efforts focus on intensive fundamental research, the proactive creation of proprietary investment advantages in carefully selected sectors and assisting managements in improving their businesses. New Mountain is a generalist firm but they tend to focus on investments in defensive growth industries. They target sectors that should succeed in both good and bad economies and are large enough and growing rapidly enough to achieve very high valuations and returns at exit. The firm has particular expertise in the following sectors: education, healthcare, logistics, business services, federal information technology services, media, software, insurance, consumer products, financial services, technology, infrastructure and energy.New Mountain looks for companies that are market leaders in sustainable growth niches and have high barriers to competitive entry as demonstrated by high operating margins and strong downside protection in all reasonable worst-case scenarios. They also look for companies that offer the opportunity for extraordinary value creation due to rapid growth or other special factors that exist at the time of the investment. Investments typically range from $100 million to $500 million per transaction.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cytel, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cytel, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cytel, Inc..